The Availability and Significance of Cost-Effectiveness Data for Informing Decisions to Add New Drugs to the National List of Health Services in Israel
- D Greenberg
- , O Wacht
- , MI Siebzehner
Research output: Contribution to journal › Meeting Abstract
Research output: Contribution to journal › Meeting Abstract